Latest Articles about CCXI

Wider-than-Expected Loss at ChemoCentryx - Analyst Blog

Zacks Equity Research — Tue, 14 May 2013 18:55:01 Z

ChemoCentryx, Inc. ( CCXI ) reported net loss of 28 cents per share in the first quarter of 2013, wider than the Zacks Consensus Estimate of a loss of 27 cents but in line with the year-ago

After-Hours Earnings Report for May 13, 2013 : CPA, IOC, POST, TTWO, WX, HMIN, CCXI, RENN, SVN, GOL, TEAR, FRF

NASDAQ.com News — Mon, 13 May 2013 22:00:05 Z

The following companies are expected to report earnings after hours on 05/13/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Copa Holdings, S.A. ( CPA ) is

Pre-Market Most Active for Apr 17, 2013 : BAC, PBR, PBR/A, YHOO, QQQ, SNY, INTC, MTU, C, CRUS, CCXI, ASML

NASDAQ.com News — Wed, 17 Apr 2013 16:39:57 Z

The NASDAQ 100 Pre-Market Indicator is down -12.48 to 2,825.93. The total Pre-Market volume is currently 36,232,895 shares traded. The following are the most active stocks for the

ChemoCentryx quiet period ends March 19

Renaissance Capital — Wed, 14 Mar 2012 15:00:04 Z

ChemoCentryx, which is developing novel drugs for Crohn's disease and rheumatoid arthritis with Glaxo, will see its quiet period end on 3/19/12. On 2/8/12, the company raised $45.0